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ELUSIDASI PENGEKSPRESAN DAN PERANAN GEN-GEN 
KAROTENOGENIK DALAM PENGHASILAN ASTAXANTHIN OLEH MUTAN 
PENGHASIL HIPER Xanthophyllomyces dendrorhous 
 
 
ABSTRAK 
 
Astaxanthin merupakan satu pigmen xantofil merah yang digunakan secara 
komersil dalam akuakultur sebagai aditif makanan haiwan dan dalam industri 
farmaseutikal berdasarkan sifat antioksidannya yang kuat. Astaxanthin sintetik bukan 
sahaja dibataskan oleh ciri-cirinya, malah keperluan proses penghasilan dan juga 
peraturan keselamatan yang ketat terhadap bahan kimia sintetik sebagai aditif makanan. 
Ini telah mendorong penghasilan astaxanthin semulajadi secara mikrobial. 
Xanthophyllomyces dendrorhous mempunyai ciri-ciri yang diingini dan nilai komersial 
sebagai sumber diet bagi astaxanthin semulajadi, tetapi ia mempunyai kandungan 
astaxanthin yang rendah secara relatif. Pelbagai cara telah digunakan untuk meningkatkan 
hasil astaxanthin termasuk pengoptimuman keadaan pertumbuhan, mutagenesis secara 
rawak dan kejuruteraan genetik. Tujuan kajian ini adalah untuk menjana satu mutan 
penghasil hiper X. dendrorhous DSM 5626 melalui mutagenesis kimia menggunakan etil 
metansulfonat (EMS) dan N-metil-N’-nitro-N-nitrosoguanidin (MNNG). Tahap ekspresi 
dan perubahan jujukan nukleotida bagi gen-gen karotenogenik dalam mutan dikaji dengan 
Real-Time PCR dan PCR masing-masing, dan dikaitkan dengan penghasilan karotenoid. 
Satu mutan dengan kebolehan penghasilan astaxanthin yang lebih tinggi berjaya 
dipencilkan daripada mutagenesis MNNG melalui pengskrinan β-ionone, dengan jumlah 
xvii 
 
kandungan karotenoid sebanyak 602.36 µg/g berbanding dengan 285.71 µg/g bagi strain 
jenis liar, iaitu peningkatan sebanyak 110.83%. Berbanding EMS, rawatan dengan 
MNNG menghasilkan kadar kematian yang lebih tinggi dalam sel-sel penerima dan lebih 
efektif dalam menginduksikan mutan berpigmen dengan warna merah gelap dan saiz 
koloni yang lebih besar menunjukkan kandungan astaxanthin yang lebih tinggi dan 
pertumbuhan sel yang lebih baik, dengan kadar mutasi terbalik yang lebih rendah. Tiada 
mutasi terbalik diperhatikan dalam mutan M34 dalam kajian kestabilan dan M34 didapati 
stabil dalam pertumbuhan sel dan penghasilan astaxanthin sepanjang seluruh tempoh 
penyelidikan ini. Dalam HPLC fasa terbalik, puncak utama bagi ekstrak M34 telah 
dikenalpasti sebagai astaxanthin berdasarkan masa retensi dan spektrum penyerapan 
bebanding dengan standard sahih astaxanthin. Keputusan pengekspresan gen 
menggunakan Real-Time PCR menunjukkan bahawa kedua-dua gen crtE and crtS 
memberikan pengekspresan yang lebih tinggi berbanding dengan strain jenis liar 
sepanjang kitaran penghasilan, yang paling tinggi sebanyak 1.3 and 3.8 kali ganda masing-
masing. Sementara gen-gen idi, crtYB, crtI and crtR tidak menunjukkan korelasi bermakna 
antara tahap transkripsi mRNA dengan penghasilan karotenoid. Corak pengekspresan gen 
adalah serupa apabila M34 dikultur dengan sama ada glukosa atau sukrosa sebagai sumber 
karbon untuk kesemua enam gen-gen crt. Selain itu, kesemua enam gen-gen 
karotenogenik mempamerkan sejumlah 38 perubahan nukleotida selepas mutasi. 
Walaupun kebanyakan perubahan nukleotida membawa kepada mutasi senyap, satu 
mutasi missense didapati di gen idi (EA) dan gen crtI (HQ), manakala dua mutasi 
missense dijumpai dalam gen crtE (KR; SD) dan gen crtR (SV; QP). Kajian ini 
akan membantu dalam memahami peranan gen-gen carotenogenik dalam 
penambahbaikan penghasilan karotenoid. 
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ELUCIDATION OF THE EXPRESSION AND ROLE OF CAROTENOGENIC 
GENES IN ASTAXANTHIN PRODUCTION IN A HYPER-PRODUCING 
MUTANT OF Xanthophyllomyces dendrorhous 
 
 
ABSTRACT 
 
Astaxanthin is a red xanthophyll pigment which is commercially used in 
aquaculture as feed additive and in pharmaceutical industries due to its strong antioxidant 
properties. Synthetic astaxantin is limited by its properties, production requirements and 
also the strict regulations concerning the safety of synthetic chemicals as food additives. 
This has led to the alternative microbial production of natural astaxanthin. 
Xanthophyllomyces dendrorhous has desirable properties and commercial value as a 
dietary source of natural astaxanthin, but it has relatively low content of astaxanthin. 
Various methods had been applied to improve the astaxanthin yield including optimization 
of culture conditions, random mutagenesis and genetic engineering. The aim of this study 
was to generate a stable astaxanthin hyperproducing mutant of X. dendrorhous DSM 5626 
through chemical mutagenesis using ethyl methanesulfonate (EMS) and N-methyl-N′-
nitro-N-nitrosoguanidine (MNNG). The expressions levels and changes of nucleotide 
sequence of carotenogenic biosynthesis genes were studied by Real-Time PCR and PCR 
resepectively, and correlated to the carotenoid production. A hyperproducing mutant, M34, 
was successfully isolated from MNNG mutagenesis through β-ionone screening, with a 
higher total carotenoid content of 602.36 µg/g compared to 285.71 µg/g in wild type strain, 
which was a 110.83% increment. Compared to EMS, MNNG treatment led to higher 
xix 
 
lethality in recipient cells and was more effective in inducing the pigmented mutants with 
intense red colour and bigger colony indicating higher astaxanthin content and cell growth, 
with lower rate of reverse mutation. No reversion was observed in M34 mutant during 
stability test and M34 mutant was found to be stable in its cell growth and astaxanthin 
production throughout the whole research period. In reversed-phase HPLC, the major 
peak in M34 mutant extract was identified as astaxanthin based on the retention time and 
absorption spectrum compared to authentic astaxanthin standard. Gene expression results 
by Real-Time PCR showed that both crtE and crtS genes showed significantly higher 
expressions relative to wild type throughout the production cycle, the highest being 1.3 
and 3.8 folds, respectively. Meanwhile idi, crtYB, crtI and crtR genes did not show 
meaningful correlation between their mRNA transcription levels and carotenoid 
production. The gene expression patterns were similar when M34 mutant was cultured 
with either glucose or sucrose as carbon source for all six crt genes. Besides, all six 
carotenogenic genes exhibited a total of 38 nucleotide changes after mutation. Although 
most of the nucleotide changes led to silent mutations, there was a missense mutation 
found in idi gene (EA) and crtI gene (HQ), while two missense mutations occurred 
in crtE (KR; SD) and crtR genes (SV; QP). This study will help in understanding 
the role of the carotenogenic genes in further improvement of carotenoid production. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
Astaxanthin, also known as 3,3’-dihydroxy-β,β-carotene-4,4’-dione, is a ketocarotenoid 
synthesized by several species of plants and microorganisms including algae, bacteria, and 
fungi. It is a valuable red xanthophyll pigment with a high biotechnological interest, 
predominantly in the aquaculture, poultry industry and cosmetology, as a pigmentation 
source and in the food and pharmaceutical industries mainly for its outstanding antioxidant 
properties and other beneficial effects on human health (Ranga Rao et al., 2014).  
 
Astaxanthin is one of the most important pigments in the nature as it is responsible for the 
orange-red colour in microorganisms and marine species such as salmon, trout, lobster, 
shrimp and other seafood besides bird species including flamingo and quail (Chimsung et 
al., 2014). However, these marine species cannot produced the astaxanthin de novo, but 
obtain it from their diet (Bon et al., 1997; Kamath et al., 2008). Thus, astaxanthin is 
conventionally used as feed additives for aquaculture and poultry industry. In aquaculture 
and poultry industry, it is used as a colouring agent to increase the organoleptic value and 
characteristics preferred by the consumer especially in lobster, shrimp, salmon, fish eggs 
and egg yolk, since the bright colour could be more attractive. It was later found that 
astaxanthin possesses strong antioxidant properties, which has been reported to outclass 
other carotenoids, including β-carotene and α-tocopherol (Lauritano & Ianora, 2016). 
Many studies have shown that astaxanthin is capable in promoting human health through 
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the prevention and treatment of various diseases including cancers, inflammatory diseases, 
diabetes, cardiovascular diseases, gastrointestinal diseases, neurodegenerative diseases, 
eye diseases and skin diseases. Consequently, astaxanthin is used as an ingredient in 
nutraceutical, medicinal and food products (Rodríguez-Sáiz et al., 2010; Tanaka et al., 
2012). Due to its biological functions in various aspects, astaxanthin obtains significant 
economic value and a growing global commercial market, thus attracts the interest and 
attention from researchers and industries to put in more efforts in astaxanthin-related 
research. 
 
Generally, astaxanthin production has been performed through chemical synthesis and this  
synthetic astaxanthin covers most of the world markets (Britton et al., 1996). Compared 
to natural astaxanthin, the chemical synthesis is recognized as the lowest cost production 
process of astaxanthin, which very likely to be its advantage to remain as the primary 
pigment source as animal feed (Schmidt et al., 2011). However, the production processes 
rely on total synthesis approaches, involving a rather long series of chemical steps ending 
with a C20+C20 reaction or a C19+C2+C19 reaction. Chemical synthesis of astaxanthin 
is dependent on petrochemicals as raw material which is not environmental friendly and 
sustainable. Synthetic carotenoids cannot be absorbed effectively by the body compared 
with other natural sources due to difference in isomer content, where astaxanthin from 
natural sources has optically pure chirality, while synthetic astxanthin consists of a 
mixture of enantiomers (3R,3'R and 3S,3'S) and mesoform (3R,3'S and 3S,3’R) (Lorenz 
& Cysewski, 2000). Furthermore, the chemical product cannot be labeled as a natural 
product, and thus does not penetrate the higher value and fastgrowing market segments. 
The consumption of synthetic pigments at high dose ranges has eventually been warned 
3 
 
by Food and Drug Administration since it might cause precarious effects to human health 
(Kläui & Bauernfeind, 1981). Only the astaxanthin obtained from algal and yeast are 
approved for human consumption, while the synthetic form is used only for animal feed 
purpose. This may be due to the insecure usage of petrochemicals for astaxanthin 
production since it was reported to be cancer-causing (Newsome, 1986). All these coupled 
with increasingly stringent regulations regarding the safety of chemicals to be used as food 
additives results in the preference for natural carotenoid products over synthetic pigments. 
However, there are also limitations for the production of astaxanthin by biological systems 
in industries such as the low astaxanthin yields in wild type strains and extraction methods 
which are costly compared to synthetic astaxanthin (Johnson & Schroeder, 1996; 
Canizares-Villanueva et al., 1998). Table 1.1 shows the sustainability comparison of 
different astaxanthin production methods.  
 
Table 1.1 Sustainability comparison of different astaxanthin production methods 
(Nguyen, 2013)  
 
 
The concerns on chemical additives in foods and feed from the public and government 
have triggered research on natural sources to produce astaxanthin by biotechnology 
(Echavarri-Erasun & Johnson, 2004). There are only a few microorganisms reported to 
have the ability to synthesize astaxanthin, including the basidiomycetous yeast, Phafﬁa 
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rhodozyma; the green alga, Haematococcus pluvialis and the bacteria, Agrobacterium 
aurantiacum, Paracoccus sp., Chlorococcum, Chlorella zofingiensis, Brevibaterium and  
Mycobaterium lacticola (Goswami et al., 2010). The heterobasidiomycetous yeast, X. 
dendrorhous is currently known as one of the most potential microorganism for synthesis 
of astaxanthin at industrial scale besides H. pluvialis (Ranga Rao et al., 2010).  
  
Currently the H. pluvialis is the primary contributor to astaxanthin market for human 
consumption (Kidd, 2011).  However, H. pluvialis has limitations in its own 
characteristics, such as its tough cell wall that traps the astaxanthin, complicating the 
extraction process and yield of production. At the same time, disadvantages such as long 
growing period, low cell densities, ease of contamination by other bacteria and even 
protozoa and finally susceptibility to adverse weather conditions, have magnified the 
weakness of the algae, especially during the scale up for mass industrial production 
(Retamales et al., 1998; Ukibe et al., 2008; Rodríguez-Sáiz et al., 2010). 
 
Due to the shortcomings of the algae, researchers see the potential of X. dendrorhous to 
replace H. pluvialis as the main source, as the yeast produces astaxanthin as its principle 
carotenoid while having high metabolism and high cell densities can be achieved in 
fermenters. Besides rapid breeding, short growth cycle, and fully developed fermentation 
process (Bhatt et al., 2013), X. dendrorhous is also able to grow on molasses, enzymatic 
wood hydrolysates, corn wet-milling co-products, corn syrup, grape juice and date juice, 
which were by-products from agricultural activities (An et al., 2001; Ramirez et al., 2006; 
Zheng et al., 2006). This gives the yeast more advantages compared to H. pluvialis.  
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However, the disadvantage of X. dendrorhous compared to H. pluvialis is its rather low 
yield of astaxanthin in wild type strains with speciﬁc production at 200–400 mg/g of dry 
yeast. The commercialized grown alga cells contains astaxanthin up to 3% of their dry 
cell mass, while astaxanthin in wild type strains of X. dendrorhous is below 0.1% (Johnson 
& Schroeder, 1996).  Various methods had been attempted to improve the yield of 
astaxanthin in X. dendrorhous, including optimization of culture condition such as 
modifying the  concentration of glucose or carbon/nitrogen ratio, the use of low cost raw 
materials, temperature, pH, oxygen content, selective addition of chemical precursors such 
as mevalonic acid, ethanol, acetic acid and lycopene, illumination with white and UV light, 
strain improvement through genetic engineering and random mutagenesis (Schmidt et al., 
2011). This will help to make X. dendrorhous more competitive in becoming the main 
source of astaxanthin for large scale production in industrial processes. 
 
1.2 Significance of the Study 
Astaxanthin is a valuable red xanthophyll pigment with a high biotechnological interest, 
mainly in the aquaculture, poultry industry and cosmetology, as a pigmentation source 
and as an antioxidant agent in the food and pharmaceutical industries due to its potent 
antioxidant properties and other beneficial effects on human health. This contributes to its 
high market value and growing demand. Traditionally this colourant and anti-oxidant in 
the market has been produced by chemical synthesis using petroleum-derived raw 
materials. Chemical synthesis of astaxanthin is disadvantaged by its dependence on 
petrochemical which is not environmental friendly and sustainable as raw material, other 
than involving a rather long series of chemical steps in the synthesis reaction. Apart from 
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that, strict regulations regarding the safety of synthetic chemical as food additives have 
been implemented from time to time and the poor absorption of synthetic astaxanthin 
compared with that from biological sources may give preference on natural astaxanthin 
products over synthetic pigments. 
 
The current growing demand for natural pigments favours the use of natural sources. Thus, 
H. pluvialis and X. dendrorhous become best choices as the main source for astaxanthin.  
However, H. pluvialis has its limitation during mass production such as its tough cell wall 
complicating the extraction process and yields. It is also disadvantaged by slow growing 
rate, low cell densities, ease of contamination by other bacteria and protozoa, and 
vulnerability to the unfavorable weather conditions. As an alternative, X. dendrorhous 
produces astaxanthin as the principle carotenoid, while having high metabolism, short 
growth cycle, high cell density and mature fermentation process as well as being able to 
grow on by-products from agriculture. This gives the yeast more advantages compared to 
H. pluvialis but it is limited by its rather low yield of astaxanthin in wild type strains with 
speciﬁc production at 200–400mg/g of dry yeast. Various approaches have been attempted 
to increase the astaxanthin production of X. dendrorhous including optimization of 
fermentation methodologies, application of chemical stimulants, genetic engineering and 
mutagenesis.  
 
Despite the rapid developments in the field of carotenoid biosynthesis, there are only few 
reports on the genes or enzymes that mediate astaxanthin metabolism, especially the 
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carotenogenic genes. It is of utmost importance to generate knowledge on the astaxanthin 
biosynthetic pathway at the level of biosynthetic genes and understand the role of these 
carotenogenic genes in improving and/or modifying astaxanthin biosynthetic pathway. 
Therefore, it is our interest to obtain a hyperproducing X. dendrorhous mutant by chemical 
mutagenesis, determine the possible mutations in its carotenogenic genes involved in the 
biosynthesis of astaxanthin and their transcription levels in the mutant and subsequently 
the possible influence of carbon sources on their transcription levels. By characterizing 
the possible alteration in these carotenogenic genes in a mutant and elucidating the 
transcription levels of these carotenogenic genes in relationship to astaxanthin 
biosynthesis, we aim to identify gene targets that can be genetically manipulated to 
improve astaxanthin production. The effect of different carbon sources on the mRNA 
expression of the carotenogenic genes was studied. Maximum carotenoid biosynthesis 
may be achieved through over-expression of crt genes in combination with advantageous 
cultivation conditions. The mutant crt genes can be used to develop new strains of X. 
dendrorhous with enhanced astaxanthin content or for the production of new xanthophylls. 
The findings may allow a rational amplification of astaxanthin production, either in X. 
dendrorhous or in alternative microbial systems for large scale carotenoid production. 
This all-round genetic approach constitutes the crucial steps towards the development of 
X. dendrorhous as a cell factory for carotenoid production which may be competitive 
economically with chemical synthesis.  
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1.3 Objectives 
The aim of this study is to understand and identify the role of carotenogenic genes 
involved in the production of astaxanthin in a hyperproducing mutant of X. dendrorhous 
and the objectives of the study are: 
 
1. To generate a X. dendrorhous mutant with higher astaxanthin production capacity 
by chemical mutagenesis. 
2. To elucidate the transcription levels of the carotenogenic genes in relationship to 
astaxanthin biosynthesis. 
3. To study the effect of mutagenesis on the nucleotide sequences of carotenogenic 
genes in the mutant. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Carotenoids 
2.1.1 Background  
Carotenoids are lipid-soluble pigments with colours, usually in orange, red or yellow 
colour that are able to absorb light in the range of 300-600 nm of wavelength. They are 
important natural pigments occur in nature throughout the photosynthetic systems of 
plants and phototrophic microorganisms including algae, yeast, cyanobacteria and fungi, 
which are the main sources for isolation and production of carotenoids at big scale (Blanco 
et al., 2007; Nelis & DeLeenheer, 1991; Bourgaud et al., 2001; Olaizola, 2003). Animals 
can only obtain carotenoids from their diet since they cannot synthesize carotenoids de 
novo (Britton et al., 2009).  
 
Carotenoids consist of isoprene residues and a C40 hydrocarbon polyene chain of 
conjugated double bonds (Sandmann & Misawa, 2002; Alcaíno et al., 2016a). The 
polyene system not only gives carotenoids their distinctive molecular structure, but also 
their chemical properties and light-absorption characteristics. The number of conjugated 
double bonds and functional groups present in the structure of the carotenoids are 
contributing to their light absorption ability. The presence of double bonds in the polyene 
chain allows the existence of two configurations in carotenoids; as geometric isomers cis 
or trans, where trans-isomers are more stable than the cis-isomers in the aspect of 
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thermodynamic. Thus, most carotenoids in nature are found typically in all trans-isomers 
(Britton, 1995; Miller et al., 2014). Structurally and functionally, carotenoids can be 
classified into carotenes (hydrocarbon derivative) and xanthophylls (oxygenated 
derivative by addition of oxygen-containing functional groups to obtain cyclic or acyclic-
xanthophylls). In xanthophyll, oxygen can be present as OH groups, which can be found 
in zeaxanthin, or as oxy-groups, which are found in cantaxanthin, or combination of both 
such as in astaxanthin. β-carotene is an example of carotene carotenoid and astaxanthin is 
a xanthopyll carotenoid (Schwab, 2011). Phytoene is produced as the first carotenoid in 
the carotenoid biosynthesis pathway, formed by condensation of two geranyl-geranyl 
diphosphate (GGDP) molecules (C20 hydrocarbon), which results in a basic symmetrical 
acyclic C40 hydrocarbon backbone structure. This carotenoid is important as the precursor 
to undergo enzyme-mediated biochemical reactions for the synthesis of other natural 
carotenoids. 
  
The presence of polyene system in carotenoids contributes to its distinctive characteristics 
in molecular structure, chemical properties and ability to absorb light. The molecule of 
carotenoid provides antioxidant properties when it introduces a ring structure joined to its 
carbon chain (DellaPenna & Pogson, 2006). Other than their significant antioxidant 
activities and important role in inhibiting the onset of chronic diseases such as 
cardiovascular disease, diabetes and age related macular degeneration, carotenoids are 
involved in numerous other biological functions including vitamin A synthesis, gap 
junction communication, immune system modulation and antitumor activity (Nishino et 
al., 2002; Minatel et al., 2017). The discoveries of beneficial properties associated to these 
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bioactive phytonutrients have brought great interest in production of carotenoids in 
diverse structures for various applications. The interest in carotenoids has caused in the 
global carotenoid market value to increase considerably from $1.5 billion in 2014 to an 
expected $1.8 billion in 2019, with a compound annual growth rate (CAGR) of 3.9% 
(BCC Research, 2015). 
 
Approximately 700 naturally occurring carotenoids are identified and over 600 different 
chemical structures have been described, but just a few of them are of economical 
importance and utilized by industry commercially as colourants or health and dietary 
supplements (Takaichi et al., 1996; Amorim-Carrilho et al., 2014; Arvayo-Enriquez et al., 
2013; Merhan, 2017).  Only a few carotenoids can be produced commercially, such as β-
carotene, lycopene, astaxanthin, canthaxanthin, capsanthin, lutein, β-apo-8-carotenal, β-
apo-8-carotenal-ester, through processes such as chemical synthesis and fermentation 
(Johnson & Schroeder, 1996). Among them, astaxanthin is the most valuable carotenoid 
to be studied due to its outstanding antioxidant and pigmentation properties. 
  
2.1.2  Astaxanthin 
2.1.2(a)  Structures and Chemical Forms of Astaxanthin  
Astaxanthin is a carotenoid with a chemical formula C40H52O4, with a molecular mass of 
596 Da (Goswami et al., 2010). It is a xanthophyll because of the presence of oxygen 
atoms besides carbon and hydrogen atoms. Astaxanthin is composed of eight isoprenoid 
units in the polyene chain, with two terminal rings that contain oxygen (Ducrey Sanpietro 
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& Kula, 1998; Alcaino et al., 2014). It is derived from a central phytoene “backbone” of 
40 carbon atoms, which is linked by single and double bonds alternatively, which is 
terminated on either end by ionone rings. At the 3, 3’ positions of the β-ionone ring, there 
are two asymmetric carbons with the presence of hydroxyl group (-OH) on either end of 
the molecule (Figure 2. 1).  
 
Figure 2.1  Chemical structure of astaxanthin (Urich, 1994) 
 
This structure plays a role in the transfer and dissipation of energy, and at the same time 
contributes to the characteristic colours of the carotenoids. The presence of oxygen-
containing functional groups on these rings not only decides the classification of 
astaxanthin as  a xanthophyll, but also allows astaxanthin to be esterified by the presence 
of these hydroxyl and keto groups and contribute to its higher antioxidant activity and its 
high polarity compared to other related carotenoids (Guerin et al., 2003; Kroll, 2006). The 
arrangement of thirteen conjugated double bonds in alternating single-double bonds 
contribute to strong antioxidant properties for scavenging activity of reactive oxygen 
species (ROS) and neutralizing the free radicals (Miki, 1991; Vershinin, 1999; Gomez 
Gomez & Estebanez, 2016; Haq et al., 2016).  
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In nature, astaxanthin exists in different isomeric forms which can be categorized 
accordingly to geometric isomers (cis/trans), stereoisomers (R/S), and free or esterified 
forms (Higuera-Ciapara et al., 2006). Each double bond found in the polyene chain in the 
astaxanthin molecule allow the existence of the molecule in two configurations: cis or 
trans, which belong to geometrical isomers as shown in Figure 2.2.  
 
 
 
 
 
Figure 2.2  Geometrical isomers of astaxanthin. (a) All-trans-astaxanthin; (b) 9-cis-
astaxanthin; (c) 13-cis-astaxanthin (Wang et al., 2008) 
(a) 
(b) 
(c) 
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Majority of natural carotenoids are principally all trans-isomers. Trans-isomer of 
astaxanthin is the predominant geometric isomer found in H. pluvialis (Yuan & Chen, 
1998).  Because of the steric reason, the isomerization of trans-astaxanthin into cis-trans 
mixtures, especially 9-cis and 13-cis, usually cannot be prevented. Among the geometric 
isomers, it was found that astaxanthin isomer in cis form, especially 9-cis astaxanthin, has 
a higher antioxidant capability than that of the all-trans isomer, which can be arranged in 
the order of 9-cis > 13-cis > all-trans (Liu & Osawa, 2007). In addition, compared to trans-
astaxanthin that consists of shorter chain length, the cis-astaxanthin is able to accumulate 
especially in blood plasma (Bohn, 2008).  
 
Isomers of astaxanthin molecule may present in three optical stereo configurations: two 
enantiomers (3R, 3′ R and 3S, 3′S) and a meso form (3R, 3′ S), as each astaxanthin 
molecule consists of two chiral centers in C-3 and C-3′, as shown in Figure 2.3.  
 
The 3S, 3′ S is the most abundant form in nature. >98% of astaxanthin produced by X. 
dendrorhous is in (3R,3’R) form and microalgae H. pluvialis synthesizes only (3S, 3’S) 
isoform (Hussein et al., 2006). Meanwhile synthetic astaxanthin like Carophyll Pink (La 
Roche) consists of a racemic mixture with the two enantiomers (3R,3’R) and (3S, 3’S) 
equally at 25% and 50% of the meso form.  
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Figure 2.3 Optical stereoisomers of astaxanthin. (a) (3S,3’S)-all-trans-astaxanthin; (b) 
(3R,3’S)-all-trans-astaxanthin; (c) (3R,3’R)-all-trans-astaxanthin (Osterlie 
et al., 1999) 
 
Astaxanthin exists in three forms: free, monoester and diester (Torrissen et al., 1989). Free 
astaxanthin particularly undergoes oxidation easily. Thereupon, in its natural state, 
astaxanthin is usually either conjugated with proteins or converted into mono- or diester 
forms by chemically bound to one or two fatty acids. On each of the terminal ring of 
(a) 
(b) 
(c) 
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astaxanthin, there is a free (unreacted) hydroxyl (OH) groups. These allow astaxanthin 
molecule to exist in free form, or can be esterified to form an ester. Addition of a fatty 
acid to form an ester leads to higher hydrophobicity on the esteriﬁed end of the molecule, 
where the strength of hydrophobicity (difﬁculty in dissolving in water) in different form 
can be observed in the sequence of diesters>monoesters>free. Astaxanthin from different 
organisms exhibited different compositions of the free form and esterified forms as shown 
in Figure 2.4. 
 
 
 
Figure 2.4  Astaxanthin and its esters from various sources (Lorenz, 1999)  
 
Although xanthophyll esters seem to be of low bioavailability, but contradicting findings 
were also reported. Sugawara et al. (2009) suggested that the presence of enzymatic 
activity after intestinal absorption led to the esterification of consumed xanthophylls and 
followed by the incorporation of xanthophyll esters into the lipid core in chylomicron 
before being carried into various tissues of the body. The esterification of xanthophylls 
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into highly nonpolar products could also contribute in the protection of intestinal cells 
from the cytotoxic effects. Thus, the accumulation of astaxanthin in H. pluvialis in ester 
form might be an added advantage to provide positive influence to the higher 
bioavailability of astaxanthin (Ranga Rao et al., 2010). 
 
2.1.2(b)  Analysis of Astaxanthin 
Multiple techniques, including spectrophotometry, thin layer chromatography (TLC), 
high performance liquid chromatography (HPLC) and nuclear magnetic resonance 
spectroscopy (NMR), have been developed to analyze and characterize the carotenoids 
profile, along with the chemical structures, for various specific species of organisms. 
Among them, UV spectrophotometry and HPLC are commonly employed for routine 
analysis of bulk samples. 
 
Spectrometric analysis of X. dendrorhous extracts showed that it has a characteristic UV–
Vis spectrum. The spectrum showed a straight peak with a maximum absorbance at 309-
310 nm, and a distinctive broad spectrum band with no obvious absorption peaks and a 
maximum at 474-477 nm, corresponding to mycosporine-glutaminol-glucoside (MGG) 
and astaxanthin respectively (Figure 2.5) (Tognetti et al., 2013). 
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Figure 2.5  UV-visible spectrum of X. dendrorhous carotenoid extracts; AU: 
absorbance unit (modified from Tognetti et al., 2013) 
 
High-performance liquid chromatography is a very sensitive analysis and can elucidate 
the composition and quantity of carotenoids in an extract or sample. In most cases, 
reversed-phase high-performance liquid chromatography (RP-HPLC) is used for 
separation of carotenoids. RP-HPLC separates the molecules based on the hydrophobicity 
of molecules, in its interaction with a hydrophobic matrix. In an aqueous buffer, molecules 
are bound to the hydrophobic matrix, which plays the role as stationary phase, and eluted 
from the matrix by mobile phase which is composed of a gradient of organic solvent (non-
polar). The hydrophobic matrix usually built up by attachment of spherical silica beads 
(3-5 micron) with linear octadecane groups (C18) to the surface through formation of 
covalent bonds. The surface area of the beads which is available for binding are usually 
increase by the presence of the porous. The C18 groups are very hydrophobic but in highly 
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polar solvent such as water can bind to polar molecules such as charged peptides. The 
name "reversed phase" is originated from the opposite technique of "normal phase" 
chromatography which involves the separation of molecules through their interaction with 
a polar matrix (silica beads without octadecane groups attached) in the presence of a non-
polar solvent. 
 
Two conditions can be applied during the elution process, either isocratic conditions 
where the organic solvent has constant concentration throughout the experiment, or by 
gradient elution where there is an increment in the amount of organic solvent over a period 
of time. Hence, the solutes are eluted in the order of low to high molecular hydrophobicity 
strength (Aguilar, 2004). RP-HPLC is an excellent technique especially for the analysis 
of proteins and peptides with the advantages of its forceful resolution that can be achieved 
under a wide range of conditions in chromatographic for very closely related molecules 
as well as structurally different molecules. In addition, the experiment could be done with 
the manipulation of chromatographic selectivity through the modification in mobile phase 
characteristics. Moreover, it also has high recoveries that lead to high productivity. RP-
HPLC also has sorbent materials which are stable under a wide range of mobile phase 
conditions that leads to excellent reproducibility for repeated separations carried out over 
a long period of time (Aguilar & Hearn, 1996; Mant & Hodges, 1996). 
 
Absorbance spectra of carotenoids are important criteria for their identification. The 
properties of spectra of each carotenoids are determined by the basic structure of 
carotenoids and some of the substituents (Britton, 1995). For astaxanthin, the spectrum is 
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not affected by 3-OH groups. On the other hand, a 4-keto group in conjugation with the 
polyene chain causes a shifting of the bell-shaped spectrum towards higher absorbance 
wavelength. The presence of second keto group at position 4’ resulted in a maximum 
absorbance of astaxanthin in the range of 470-477 nm in various reports. In X. 
dendrorhous, most of the carotenoids have a 3-HO-4-keto-β-ionone end group. Increment 
in the polarity will lead to decrease of the mobility of a compound in absorption 
chromatography on stationary phases like silica or reduce the retention time in reversed-
phase HPLC. Astaxanthin normally appears ﬁrst in HPLC chromatograms since it is a 
xanthophyll with high polarity. During RP-HPLC process, the expected order of elution 
is not affected by the presence of the hydrogen bond between the HO and keto group. 
Carotenoids like astaxanthin exist in different isomeric forms as discussed in Section 
2.1.2(a). Majority of astaxanthin from X. dendrorhous is all-trans form, but there are also 
small amounts of 9-cis and 13-cis isomers. These cis forms have a slightly different optical 
spectrum, where the main maximum absorbance of 9-cis and 13-cis is shifted by 5 nm 
compared to all-trans forms (Figure 2.6) (Visser et al., 2005). Other than these geometrical 
isomers, astaxanthin occurs in three optical isomers: 3R, 3’R, 3S, 3’S and 3R, 3’S but the 
optical absorbance is not affected by this chirality. 
 
For carotenoid profiling, a sample can be compared to authentic chemical standards or a 
control strain in terms of retention time and absorbance spectrum. The quantification of 
carotenoids can be determined by integration of the peak areas in HPLC chromatogram. 
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Figure 2.6  Spectra of astaxanthin geometrical isomers (Visser et al., 2005) 
 
2.1.2(c)    Biological Properties of Astaxanthin and Its Health Benefits 
Astaxanthin is a high-value ketocarotenoid mainly synthesized by several species of 
microalgae, plants, bacteria, and fungi. In X. dendrorhous and H. pluvialis, astaxanthin is 
built up through the stimulation of the environmental stress, and protects cellular DNA 
from photodynamic damage (Hagen et al., 1993). In general, animals do not have the 
ability to produce carotenoids on their own and have to obtain these compounds from their 
diets. Astaxanthin is responsible for the colour of the flesh for large amount of marine 
species through consumption of microorganisms that synthesize the pigment (Gu et al., 
1997; Olaizola, 2003; Schroeder & Johnson, 1995a; Alvarez et al., 2006). It plays a 
conventional role in poultry and aquaculture industry as the useful feed additive in 
providing characteristic pigmentation of the tissues that influences organoleptic values 
22 
 
and consumer preferences. It is also widely used as colourants in the food industry to 
ensure proper pigmentation and enhance acceptability of many foods. Astaxanthin has 
been approved by the United States Food and Drug Administration (USFDA) to be added 
in to animal and fish feed for colouration purpose (Pashkow et al., 2008), while the 
European Commission has considered natural astaxanthin as a safe food dye (Roche, 
1987).  
 
Other than foods and feeds, the use of astaxanthin in nutritional supplement has been 
growing fast in nutraceuticals and pharmaceuticals as it was discovered that the 
consumption of astaxanthin can reduce or prevent risk of various diseases in humans and 
animals (Kidd, 2011; Yang et al., 2013; Yuan et al., 2011; Dhankhar et al., 2012). The 
oxidative molecules, such as free radicals, including hydroxyls and peroxides, and reactive 
oxygen species are generated during aerobic metabolism in organisms. Excess quantities 
of such compounds might cause oxidative damage which lead to various human diseases. 
Human body can generate superoxide dismutase catalase and peroxidase as their own 
enzymatic antioxidants to control and reduce these oxidative effects. But these compounds 
are not enough most of the time, thus extra consumption of antioxidants is required. 
Astaxanthin plays the role as a strong antioxidant by reacting with free radicals through 
donation of electrons to convert them to more stable products and suspends free radical 
chain reaction in living organisms (Ranga Rao et al., 2010). Astaxanthin shows strong 
scavenging activity on free radicals and protects LDL cholesterol, cell membranes, cells 
and tissues from lipid peroxidation and oxidative damage. It is a strong antioxidant that 
protects the phospholipid cell membrane and other lipid components by removing singlet 
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oxygen and inhibiting free radicals, thus shields the plants and organisms from oxidative 
damage caused by active oxygen species (Schroeder & Johnson, 1995b). Many studies 
have revealed that astaxanthin has powerful antioxidant activity, which may be ten times 
stronger than that of other carotenoids such as β-carotene, lutein, zeaxanthin, 
canthaxanthin, and lipophilic antioxidants like vitamin E (α-tocopherol) in scavenging of 
singlet oxygen (1O2) and peroxyl radicals (H2O2). The unique structure of astaxanthin 
allow it to stay both inside and outside of the cell membrane and terminate free radical 
chain reaction on both sides of the membrane, which gives better protection when 
compared to vitamin C and β-carotene (McNulty et al., 2007; Lauritano & Ianora, 2016).  
 
Besides mitigating the damaging effects of oxidative stress, astaxanthin modulates 
stimulation of inflammation and immune response. The antioxidation properties of 
astaxanthin make it among the bioactive phytochemicals credited for reducing the risks of 
human diseases such as cancer, cardiovascular diseases and diabetes besides protection 
against UVA-induced oxidative stress (Maldonade et al., 2008). 
 
Clinical and epidemiological data showed that there might be protection effect against 
cardiovascular disease through consumption of dietary antioxidants. In human body, high 
level of Low Density Lipoprotein (LDL), the bad cholesterol, may lead to development of 
cardiovascular diseases (Maher, 2000). Astaxanthin is carried by VLDL, LDL and HDL 
in the human blood and it can improve heart health by altering levels of LDL and HDL 
cholesterol in bloods (Guerin et al., 2003). Astaxanthin supplementation prevented LDL-
cholesterol from stimulation of in vitro oxidation and induced the increment of HDL in 
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blood levels, the form of blood cholesterol negatively correlated with coronary heart 
disease (Iwamoto et al., 2000). Other than that, astaxanthin may reduce the risk of 
cardiovascular disease by lowering elevated blood pressure, inhibiting oxidation of LDL, 
stabilizing atherosclerotic plaque, lessening the risk of myocardial infarction and 
preventing atherosclerosis. The possibility of involvement of astaxanthin in nitric oxide-
related mechanism and modulation of the blood ﬂuidity might contribute to 
antihypertensive effect in human. It can also beneﬁt the heart health by reducing 
inﬂammation most likely correlated with the increasing risk of coronary heart disease 
(Tracy, 1999). Astaxanthin has the potential to become therapeutic agent against 
atherosclerotic cardiovascular disease as it is a potent antioxidant agent against 
inflammation and oxidative stress, which are the pathophysiological properties of 
atherosclerotic cardiovascular disease (Fassett & Coombes, 2011).  
 
Antioxidant compounds such as astaxanthin are capable to reduce the risk of mutagenesis 
and carcinogenesis by prohibiting cell damage caused by oxidation. Besides having higher 
antitumor activity when compared to other carotenoids such as β-carotene and 
cantaxanthin (Chew & Park, 2004), it also acts as an inhibitor for the development of 
breast and prostate cancer cells, fibrosarcoma and embryonic fibroblasts (Palozza et al., 
2009), cell death, cell proliferation and chemically induced mammary tumors (Jyonouchi 
et al., 2000; Prabhu et al., 2009; Nakao et al., 2010). Moaka et al. (2012) found that 
Epstein-Barr virus and carcinogenesis in mouse skin-papillomas were effectively 
prohibited after astaxanthin treatment. Astaxanthin may unleash anti-tumor activities 
through the promotion of immune response by preventing stress-stimulated lipid 
